Company Patenting Tech for Designing Babies
By John Fowler,
KTVU
| 11. 20. 2013
[With CGS's Marcy Darnovsky]
BERKELEY, Calif. — Parents will do just about anything to improve what they see as their children’s chance for success. But does that mean biotechnology?
Some say boosting a child’s chances before conception is ‘creepy’.
But what is wrong with a more perfect baby? One where you pick the eye color, athletic ability and disease risk?
“I guess if you could eliminate that (disease risk) that’s a pretty good thing,” said Tom Robarge of San Francisco.
Though Narkee Rosenberg said “it’s a little like playing with fate and future, and I don’t know how I feel 100 percent about that”.
Biotechnology may now give parents unprecedented choices.
“Our understanding of genetics in the last ten years has really exploded,” said 23andme scientist Emily Conley.
Fertility clinics already use pre-implantation genetic diagnosis, PGD, to select traits for some in-vitro babies. But intentional manipulation might create ethical nightmares such as in the sci-fi film GATTACA where genetics means success.
Marcy Darnovsky from the Center for Genetics and Society in Berkeley is very concerned of this possibility.
“A world of genetic haves and...
Related Articles
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...